Business
MedMira Board of Directors Elected at Annual General Meeting
HALIFAX, Feb. 2, 2012 /CNW/ - MedMira Inc., (MedMira) (TSXV: MIR), a developer and marketer...
About this update from Medmira Inc.
[{"type":"text","content":"\n\n\n\n\n\nHALIFAX, Feb. 2, 2012 /CNW/ - MedMira Inc., (MedMira) (TSXV: MIR), a\n developer and marketer of rapid diagnostic technology and solutions,\n today announced that the Company's Board of Directors was elected at\n MedMira's 2012 Annual General and Special Meeting of Shareholders,\n which was held on January 30th, 2012. Mr. Hermes Chan, Dr. Shou-Ching\n Tang, Mr. Romano Robusto and Mr. Markus Meile were re-elected as\n directors of the Company.\n\n\n\"MedMira's Board of Directors provides strategic insight and direction\n on business execution to the Company's management team as it moves\n forward on key strategies for 2012,\" said Hermes Chan, CEO and\n Director, MedMira.  \"The Company is committed to positioning itself for\n growth by building on success, including China market penetration and\n the US Army contract.  MedMira will transform structurally into\n distinct and focused business units, implement automation in its\n manufacturing processes, and restore its financial condition.  Most\n importantly, we will continue to innovate, bringing new products to\n market and building our brand in high growth niche markets.\"\n\n\nShareholders approved all other matters considered at the meeting\n including the appointment of Deloitte & Touche LLP as the Company's\n auditors and ratification of the stock option plan.\n\n\nAbout MedMira\n\n\nMedMira is a leading developer and manufacturer of flow-through rapid\n diagnostics and technologies. The Company's tests provide hospitals,\n labs, clinics and individuals with reliable, rapid diagnosis of\n infectious diseases. MedMira diagnostics are sold under the Reveal®,\n MiraWell®, Multiplo™, and Miriad brands in global markets. MedMira's\n rapid HIV test is the only rapid HIV test in the world to achieve\n regulatory approvals in Canada, the United States, China and the\n European Union. MedMira's corporate offices and manufacturing\n facilities are located in Halifax, Nova Scotia, Canada. For more\n information visit MedMira's website at www.medmira.com.\n\n\nThis news release contains forward-looking statements, including\n statements regarding development of sales opportunities, which involve\n risk and uncertainties and reflect the company's current expectation\n regarding future events.  Actual events could materially differ fr...